Fennec Pharmaceuticals Inc (FENC)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Rostislav C. Raykov
Employees:
10
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
(919) 636-4530
-
Formally known as:
- Adherex Technologies Inc.
- Adherex Technologies Inc.
- Adherex Technologies, Inc. Ordinary
- FENNEC PHARMACEUTICALS, INC.
Date | Ratio |
---|---|
2005-08-02 | 1:5 |
2011-08-30 | 1:18 |
2014-09-05 | 1:3 |
Fennec Pharmaceuticals Inc. develops product candidates for use in the treatment of cancer in the U.S. Its lead product PEDMARK is a formulation of Sodium Thiosulfate that has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|